Loading
The Santa Monica medical oncologist whose sarcoma practice has run many of the field's early and late phase drug trials, including the aldoxorubicin programme.
Sant Chawla is Medical Director of the Sarcoma Oncology Center in Santa Monica, California, a sarcoma-focused practice that its site describes as offering access to clinical trials and novel investigational therapies alongside multimodal treatment planning. He is board certified in internal medicine and medical oncology. OnCo's record of the centre notes that he led the aldoxorubicin trials in soft tissue sarcoma and co-founded Gemini Therapeutics, the company formed to carry aldoxorubicin forward. His publications are listed on PubMed.
These papers come from a Europe PMC search on the author's name and institution, taking the most cited articles.
Shares Aldoxorubicin, Aldoxorubicin versus investigator's choice in relapsed or refractory soft tissue sarcoma.
Shares Osteosarcoma, Sarcomas (soft tissue, bone, GIST) and the tag trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tag trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tag trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tag trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tag trialist.
Shares Sarcomas (soft tissue, bone, GIST) and the tag trialist.
Shares Osteosarcoma, Sarcomas (soft tissue, bone, GIST) and the tag trialist.